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The Clearance Mechanism of Chilled Blood Platelets
Spurej et al., 2001). Based on studies linking signalingKarin M. Hoffmeister,1,* Thomas W. Felbinger,3,4
to the mechanisms leading to platelet shape changesHerve´ Falet,1 Ce´cile V. Denis,3,4
induced by agonists (Hartwig et al., 1995), we predictedWolfgang Bergmeier,3,4 Tanya N. Mayadas,2
that chilling, by inhibiting calcium extrusion, could ele-Ulrich H. von Andrian,3,4 Denisa D. Wagner,3,4
vate calcium levels to a degree consistent with the acti-Thomas P. Stossel,1 and John H. Hartwig1
vation of the F actin severing and barbed end capping1Division of Hematology
protein gelsolin. We also reasoned that a membraneDepartment of Medicine
lipid phase transition at low temperatures would cluster2 Department of Pathology
phosphoinositides. Phosphoinositide clustering uncapsBrigham and Women’s Hospital
F actin barbed ends to create nucleation sites for fila-Boston, Massachusetts 02115
ment elongation (Janmey and Stossel, 1989). We pro-3 The Center for Blood Research
duced experimental evidence for both mechanisms,4 Department of Pathology
documenting gelsolin activation, actin filament barbedHarvard Medical School
end uncapping, and actin assembly in cooled plateletsBoston, Massachusetts 02115
(Hoffmeister et al., 2001; Winokur and Hartwig, 1995).
Others have reported myosin activation in chilled plate-
lets, consonant with increased free intracellular calcium
levels (Kawakami et al., 2001) and spectroscopicSummary
changes in chilled platelets interpreted as a membrane
phase transition (Tablin et al., 1996). This informationPlatelet transfusion is a very common lifesaving medi-
suggested a method for preserving the discoid shapecal procedure. Not widely known is the fact that plate-
of chilled platelets, using a cell-permeable calcium che-lets, unlike other blood cells, rapidly leave the circula-
lator to blunt the calcium rise and cytochalasin B totion if refrigerated prior to transfusion. This peculiarity
prevent barbed end actin assembly, and these com-requires blood services to store platelets at room tem-
pounds keep human platelets discoid in the cold (Wino-perature, limiting platelet supplies for clinical needs.
kur and Hartwig, 1995).Here, we describe the mechanism of this clearance
Since most cells round up in the cold, the response ofsystem, a longstanding mystery. Chilling platelets
platelets to chilling is an anomaly, and its physiologicalclusters their von Willebrand (vWf) receptors, eliciting
purpose unknown. Moreover, the effects of coolingrecognition of mouse and human platelets by hepatic
platelets are of more than academic importance. Hu-macrophage complement type 3 (CR3) receptors.
mans depleted of platelets by bone marrow failure sufferCR3-expressing but not CR3-deficient mice exposed
from life-threatening spontaneous bleeding, and lessto cold rapidly decrease platelet counts. Cooling
severe deficiencies of platelets contribute to bleedingprimes platelets for activation. We propose that plate-
complications following trauma or surgery. A major ad-lets are thermosensors, primed at peripheral sites
vance in medical care half a century ago was the devel-where most injuries occurred throughout evolution.
opment of platelet transfusions to correct such plateletClearance prevents pathologic thrombosis by primed
deficiencies, and over four million platelet transfusionsplatelets. Chilled platelets bind vWf and function nor-
take place annually in the United States alone (Jacobsmally in vitro and ex vivo after transfusion into CR3-
et al., 2001). Platelets, however, unlike all other trans-deficient mice. Therefore, GPIb modification might
plantable tissues, do not tolerate refrigeration, becausepermit cold platelet storage.
they disappear rapidly from the circulation of recipients
if subjected to even very short periods of chilling, andIntroduction
the cooling effect that shortens platelet survival is irre-
versible (Becker et al., 1973; Berger et al., 1998). The
Platelets are anucleate bone marrow-derived blood cells
resulting need to keep these cells at room temperature
that protect injured mammals from blood loss by adher-
(RT) prior to transfusion has imposed a unique set of
ing to sites of vascular injury and by promoting the costly and complex logistical requirements for platelet
formation of plasma fibrin clots. Circulating platelets are storage. The major practical problem with RT storage,
smooth-surfaced discs that react to thrombin and other leading to its short (5 day) limitation, is the risk of bacte-
mediators associated with vascular damage by adhering rial infection. Bacterial contamination of blood compo-
to endothelial and subendothelial surfaces. They utilize nents is currently the most frequent complication of their
actin cytoskeletal remodeling reactions to acquire com- use exceeding by far that of viral agents (Engelfriet et
plex shapes that facilitate adhesion and interactions al., 2000). The short shelf life of procured platelets cou-
with fibrin polymers formed at the injury sites. pled to fluctuating demands for platelet transfusions
Over 40 years ago, investigators noted that discoid mean that many units of procured platelets cannot be
platelets undergo similar extensive shape changes used because of outdating. This wastage rate may be
when exposed to temperatures 15C (Zucker and Bor- as high as 50% and may cost the American health care
relli, 1954), and more subtle morphological alterations system over a billion dollars annually.
are detectable even at higher temperatures (Maurer- Evidence that a discoid shape was the best predictor
of viability for platelets stored at room temperature
(Schlichter and Harker, 1976) led to the conclusion that*Correspondence: khoffmeister@rics.bwh.harvard.edu
Cell
88
the cold-induced shape change per se was responsible lets (Becker et al., 1973). Also consistent with the earlier
reports, we observed that the relatively small number offor the rapid clearance of chilled platelets. The belief is
that irregularly shaped platelets, deformed by cooling, chilled transfused platelets remaining in the circulation
after the initial clearance phase disappear at the samebecome entrapped in the microcirculation. We report
here, however, that even discoid platelets clear rapidly rate, or even somewhat slower, than RT platelets. We
have no definite explanation for these findings, but pos-from the circulation of mice. This information and other
evidence that misshapen platelets can circulate fairly sibilities are that the clearance mechanism becomes
saturated or else that a small number of platelets arenormally (Berger et al., 1998; Michelson et al., 1996) led
us to seek other mechanisms responsible for the rapid resistant to cold modification.
Figure 1C shows that the organ destinations of RTclearance of chilled platelets.
We have shown that cooling platelets rearranges the and chilled mouse platelets differ. Whereas RT platelets
primarily end up in the spleen, the liver is the majorsurface configuration of glycoprotein Ib (GPIb), a major
platelet adhesion receptor that binds activated forms of residence of chilled platelets removed from the circula-
tion. A greater fraction of radionucleotide detected in thevon Willebrand factor (vWf) deposited at sites of vascu-
lar injury. In response to cooling, the GPIb subunit of kidneys of animals receiving 111Indium-labeled chilled
compared with RT platelets at 24 hr may reflect thethe vWf receptor complex clusters and becomes tar-
geted for recognition by CR3 highly expressed on liver degradation of chilled platelets and delivery of free radio-
nuclide to the urinary system. One hour after injection,macrophages, leading to platelet phagocytosis and
clearance. Cooling, however, does not grossly impair the organ distribution of CMFDA- and 111Indium-labeled
platelets was comparable. In both cases, 60%–90% ofthe interaction between GPIb and activated vWf, im-
plying that the hemostatic and clearance functions of the chilled platelets were deposited in the liver, 10%–
20% in the spleen, and 10%–25% in the lung. In contrast,GPIb are distinct.
As the temperature falls below 37C, platelets become 25% of the infused RT platelets distributed equally
among the liver, spleen, and lung.more susceptible to activation by thrombotic stimuli, a
phenomenon we term “priming” (Faraday and Rosen-
feld, 1998; Hoffmeister et al., 2001). Such priming may Chilled Mouse Platelets Colocalize with Liver
be an adaptation to limit bleeding at lower temperatures Kupffer Cells
of body surfaces where most injuries occurred through- The clearance of chilled and rewarmed platelets by the
out mammalian evolution. We propose that the hepatic liver and the evidence for platelet degradation is consis-
clearance system’s purpose is to remove repeatedly tent with their ingestion by Kupffer cells, the major
primed platelets. Consistent with this theory, platelet phagocytic scavenger cells of the liver. Figure 1D shows
counts of WT but not of CR3 null mice exposed to cold the location of Kupffer cells and adherent chilled
temperatures rapidly fall. Since the conformational CMFDA-labeled platelets in a representative confocal-
changes in GPIb that promote this clearance do not micrograph of a mouse liver section 1 hr after transfu-
affect GPIb’s hemostatically important binding to vWf, sion. Kupffer cells were visualized by the injection of
selective modification of GPIbmay accommodate cold microspheres marked with Nile-red. Colocalization of
storage of platelets for transfusion. chilled platelets and macrophages is shown in yellow
in a merged micrograph of both fluorescence emissions.
The chilled platelets localize with macrophages prefer-Results
entially in the periportal and midzonal domains of liver
lobules, sites rich in sinusoidal macrophages (Bioulac-The Clearance of Chilled Mouse Platelets Occurs
Sage et al., 1996).Predominantly in the Liver and Is Independent
of Platelet Shape
CR3/ Mice Do Not Rapidly ClearMouse platelets kept at RT and infused into syngeneic
Chilled Plateletsmice disappear at a fairly constant rate over time for
CR3 (M2 integrin; CD11b/CD18; Mac-1) is a major me-about 80 hr (Figure 1A). In contrast, approximately two-
diator of antibody-independent clearance by hepaticthirds of platelets chilled at ice bath temperature (Cold)
macrophages. Figure 2A shows that chilled plateletsbefore injection rapidly disappear from the circulation
circulate in CR3/ mice with the same kinetics as RTas observed previously (Becker et al., 1973; Berger et al.,
platelets, although the clearance of platelets is faster in1998). Chilled platelets treated with the cell-permeable
the CR3/ mouse compared to that in wild-type (WT)calcium chelator EGTA-AM and the actin filament
mice (Figure 1A). Chilled and rewarmed platelets alsobarbed end capping agent cytochalasin B (Cold  Cy-
clear rapidly from complement factor 3/ mice (FiguretoB/EGTA) to preserve their discoid shape (Winokur and
2C), missing a major opsonin that promotes phagocyto-Hartwig, 1995), left the circulation as rapidly as chilled,
sis and clearance via CR3, and from vWf/ mice (Fig-untreated platelets despite the fact that these chemically
ure 2B).treated platelets were fully functional as determined by
thrombin-, ADP- or collagen related peptide-(CRP) in-
duced aggregation in vitro (Figure 1B). The recoveries Chilled Mouse Platelets Adhere Tightly
to Kupffer Cells In Vivoof infused platelets immediately following transfusion
were 60%–70%, and the kinetics of disappearance were The ratio between chilled and RT stored adherent plate-
lets infused simultaneously was determined. Figure 3indistinguishable whether we used 111Indium or CMFDA
to label platelets. The relative survival rates of RT and shows that both chilled and RT platelets attach to sinus-
oidal regions with high Kupffer cell density (Figure 3Achilled mouse platelets resemble the values reported
previously for mice (Berger et al., 1998) and human plate- and 3B), but that 2.5 to 4 times more chilled platelets
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Figure 1. Clearance and Function of RT and Chilled Murine Platelets
(A) Circulation time in mice of RT platelets and of platelets chilled in the presence or absence of EGTA-AM and Cytochalasin B. The curves
depict the survival of CMFDA-labeled, RT platelets, platelets chilled at ice bath temperature (Cold), and rewarmed to RT before injection and
chilled and platelets treated with EGTA-AM and cytochalasin B (Cold  CytoB/EGTA) to preserve their discoid shape. Each curve represents
the mean  SD of 6 mice. Identical clearance patterns were observed with 111Indium-labeled platelets.
(B) Chilled mouse platelets aggregate normally in vitro. Washed, chilled-rewarmed (Cold), or RT WT platelets were stimulated by the addition
of the indicated agonists at 37C. Aggregation responses of chilled platelets treated with EGTA-AM and cytochalasin B were identical to
untreated chilled platelets.
(C) Cold-induced clearance occurs predominantly in the liver of mice. The liver is the primary clearance organ of chilled platelets, containing
60%–90% of injected platelets. In contrast, RT platelets are cleared more slowly in the spleen.111Indium-labeled platelets were injected into
syngeneic mice and tissues were harvested at 0.5, 1, and 24 hr. Data are expressed per gram of tissue. Each bar depicts the mean values
of 4 animals analyzed  SD.
(D) Chilled mouse platelets colocalize with hepatic sinusoidal macrophages (Kupffer cells). This representative confocal-micrograph shows
the hepatic distribution of CMFDA-labeled, chilled-rewarmed platelets (green) after 1 hr of transfusion, which preferentially accumulate in
periportal and midzonal fields of liver lobules. Kupffer cells were visualized after injection of Nile red-labeled microspheres. Colocalization of
chilled platelets and macrophages is in yellow. The lobule organization is indicated (CV: central vein; PV: portal vein, bar: 100 M).
attach to Kupffer cells in the WT mouse than RT platelets in vitro (Simon et al., 2000), we investigated GPIb as
a possible counter receptor on chilled platelets for CR3.(Figure 3C). In contrast, the number of platelets adhering
to Kupffer cells in CR3/ mice was independent of chill- We stripped the extracellular domain of GPIb from
mouse platelets with O-sialoglycoprotein endopepti-ing or RT exposure (Figure 3C).
dase (Bergmeier et al., 2001) (Figure 4A, inset) and exam-
ined their survival in mice following RT or cold incuba-Chilled Mouse Platelets Lacking GPIb
Circulate Normally tion. Figure 4A shows that chilled platelets no longer
exhibit rapid clearance after removal of GPIb. In fact,Because GPIb, a component of the GPIb-IX-V receptor
complex for vWf, can bind CR3 under certain conditions GPIb-depleted RT-treated platelets have slightly elon-
Figure 2. Chilled Platelets Circulate Normally in CR3/ Mice, but Not in Complement 3 (C3) or vWf/ Mice
CMFDA-labeled chilled-rewarmed (Cold, filled circles) and RT (open circles) WT platelets were transfused into six each of syngeneic CR3/
(A), vWf/ (B), and C3/ (C) recipient mice and their survival times determined. Chilled platelets circulate in CR3/ animals with the same
kinetics as RT platelets, but are cleared rapidly from the circulation of C3 or vWf/ mice. Data are mean  SD for 6 mice.
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Figure 3. Chilled Platelets Adhere Tightly to CR3-Expressing Mouse Macrophages In Vivo
(A) Chilled-rewarmed TRITC-labeled platelets adhere with a higher frequency to liver sinusoids than RT CMFDA-labeled platelets. 30 min after
the infusion of the platelets (B) chilled-rewarmed (Cold, open bars) and RT platelets (filled bars) adhere to sinusoidal regions with high
macrophage density (midzonal) with similar distributions in WT mice.
(C) Chilled-rewarmed platelets adhere 3–4 	 more than RT platelets to macrophages in the WT liver (open bars). In contrast, chilled-rewarmed
or RT platelets have identical adherence to macrophages in CR3/ mice (filled bars). Nine experiments with WT mice and 4 experiments with
CR3/ mice are shown (mean  SEM, * p  0.05: ** p  0.01).
Figure 4. GPIb Mediates Chilled Mouse
Platelet Clearance but Binds Activated vWf;
vWf-Receptor Aggregates on the Surface of
Chilled Platelets
(A) CMFDA-labeled mouse platelets enzy-
matically cleared of GPIb (left image, inset,
filled area) or control platelets were kept at RT
(left image) or chilled-rewarmed (right image)
infused into syngeneic WT mice, and platelet
survivals were determined. (Mean values 
SD for 6 mice).
(B) Chilled, or RT platelet rich plasma was
treated with (shaded area) or without (open
area) botrocetin. vWf bound was detected us-
ing FITC-labeled anti-vWf antibody.
(C) The vWf receptor redistributes from linear
arrays (RT) into aggregates on the surface
of chilled murine platelets (Cold). GPIb is
visualized with 10 mm immunogold. The bars
are 100 nm. Inset: low magnification of
platelets.
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Figure 5. GPIb-CR3 Interaction Mediates Phagocytosis of Chilled Human Platelets In Vitro
THP-1 cells were incubated with RT (A) or chilled-rewarmed (Cold) platelets (B). CM-Orange-labeled platelets associated with macrophages
shift in orange fluorescence up the y-axis. Chilling of platelets increases their phagocytosis from 4% to 20%. Platelets were ingested,
because they do not dual label with the FITC-mAb to CD61.
(C) Undifferentiated (open bars) THP-1 cells express 50% less CR3 than differentiated cells and ingest half as many chilled-rewarmed
platelets. Differentiation (filled bars) of CR3 expression leads to a 2-fold increase in chilled-rewarmed platelet phagocytosis, but has no
significant effect on the uptake of RT platelets. Treatment of human platelets with mocarhagin (Moc), which removes GPIb from the surface
(inset; control: solid line, mocarhagin treated platelets: shaded area), reduced phagocytosis of chilled platelets by98%. The mean percentage
of the CM-Orange positive native macrophages incubated with RT kept platelets was normalized to 1. Data shown are means  SD of 5
experiments.
gated survival times (5%–10%) when compared to the Exclusion of Other Mediators of Cold-Induced
Platelet ClearanceGPIb-containing RT controls.
Table 1 shows results of experiments that examined
whether cooling affected the expression of human andChilling Clusters GPIb on the Platelet Surface
but Does Not Affect Binding of Activated vWf mouse platelet receptors other than GPIb or their inter-
action with ligands. These experiments revealed no de-to Mouse Platelet vWf-Receptors
Figure 4B shows that botrocetin-activated vWf binds tectable effects on the expression of P selectin, IIb3-
integrin density, or fibrinogen binding, a marker of IIb3platelets equally well at RT and in the cold. However,
chilling of platelets redistributes GPIb on the murine activation. Chilling also did not increase phosphatidyl-
serine (PS) exposure, an indicator of apoptosis, nor did itplatelet surface. GPIb molecules, identified by anti-
GPIb immunogold, form linear aggregates on the surface change platelet binding of IgG or IgM immunoglobulins.
of resting platelets at RT (Figure 4C, RT), an arrangement
consistent with their connection to underlying F actin Circulating Chilled Platelets Have Hemostatic
by filamin A (Hartwig and DeSisto, 1991). After chilling Function in CR3/ Mice
(Figure 4C, Cold), many GPIb molecules organize as Despite their rapid clearance in WT mice, chilled plate-
clusters over the platelet membrane deformed by inter- lets were functional 24 hr after infusion into CR3/mice,
nal actin rearrangements (Hoffmeister et al., 2001). Cool- as determined by three independent methods. First,
ing of human platelets also caused clustering of GPIb chilled platelets incorporate into platelet aggregates in
molecules (data not shown). shed blood emerging from a standardized tail vein-
bleeding wound (Figure 6). CMFDA-positive RT platelets
Recognition of GPIb by CR3-Mediates
Phagocytosis of Chilled Human
Platelets In Vitro
Table 1. Effect of Chilling on Binding of Various Antibodies or
Differentiation of monocytoid THP-1 cells using TGF-1 Ligands to Platelet Receptors.
and 1,25-(OH)2 vitamin D3 increases expression of CR3
Binding ratio 4C: 22Cby 2-fold (Simon et al., 2000). Chilling resulted in an3-
fold increase of platelet phagocytosis by undifferenti- Platelet receptor (ligand) Human platelets Murine platelets
ated THP-1 cells and an 5-fold increase by differenti-
P Selectin 1.01  0.06 1.02  0.03
ated THP-1 cells (Figures 5B and 5C), consistent with Platelet associated IgGs 1.05  0.14 1.06  0.03
mediation of platelet uptake by CR3. In contrast, the Platelet associated IgMs 0.93  0.10 1.01  0.02
differentiation of THP-1 cells had no significant effect Phosphatidylserine (annexin V) 0.95  0.09 1.04  0.02
IIb3 (anti-CD61 mAb) 1.03  0.05 1.04  0.10on the uptake of RT stored platelets (Figures 5A and
IIb3 (fibrinogen) 1.05  0.10 1.06  0.065C). To determine if GPIb is the counter receptor for
CR3-mediated phagocytosis of chilled human platelets, The binding of fluorescently labeled antibodies or ligands against
various receptors on chilled-rewarmed or RT human and murinewe removed the extracellular domain of GPIb using
platelets was measured by flow cytometry. The data are expressedmocarhagin (Ward et al., 1996). Removal of GPIb from
as the ratio of fluorophore bound to the surface of chilled versusthe surface of human platelets reduced their phagocyto-
RT platelets (mean  SD, n 
 3–4).
sis after chilling by 98% (Figure 5C).
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Figure 6. Circulating, Chilled Platelets Have Hemostatic Function in CR3/ Mice
Normal in vivo function RT platelets transfused into WT mice (A and B) and of chilled (Cold) platelets transfused into CR-3/ mice (C and
D), as determined by their equivalent presence in platelet aggregates emerging from the wound 24 hr after infusion of autologous CMFDA
labeled platelets. Platelets in peripheral blood (A and C) and the blood emerging from the wound (shed blood, B and D) were identified by
forward light scatter characteristics and binding of the PE-anti-GPIb mAb (pOp4). The infused platelets (dots) were CMFDA fluorescence
positive, non-infused platelets (contour lines) were fluorescence negative. The percentages refer to the number of aggregates formed by
CMFDA-positive platelets (n 
 4).
(E) Ex vivo function of CM-Orange, RT platelets transfused into WT mice and CM-Orange, chilled-rewarmed (Cold) platelets transfused into
CR3/ mice, as determined by exposure of CD62P (P selectin) and fibrinogen binding following 1 U/ml thrombin activation of blood drawn
from the mice after 24 hr post infusion. Transfused platelets were identified by CM-Orange fluorescence (filled bars); non-transfused (unlabeled)
platelets are the open bars. Results are expressed as the percentage of cells present in the P selectin and fibrinogen positive regions (mean 
SD, n 
 4).
transfused into WT mice (Figure 6B) and CMFDA-posi- Discussion
tive chilled platelets transfused into CR3/ mice (Figure
Cold-Induced Platelet Shape Change Alone Does6D) formed aggregates in shed blood to the same extent
Not Lead to Platelet Clearance In Vivoas endogenous platelets. Second, as determined by
Cooling rapidly induces extensive platelet shape changesplatelet surface exposure of the fibrinogen binding site
mediated by intracellular cytoskeletal rearrangementson IIb3 24 hr after transfusion of CM-Orange-labeled
(Hoffmeister et al., 2001). These alterations are partiallychilled and rewarmed platelets into CR3/ mice follow-
but not completely reversed by rewarming, and re-ing ex vivo stimulation by thrombin. Third, CM-Orange
warmed platelets remain more spherical than discoid.labeled platelets chilled and rewarmed were fully capa-
The idea that preservation of discoid shape is a majorble of upregulation of P selectin in response to thrombin
requirement for platelet survival has been a dogma, de-activation (Figure 6E). In addition to these experiments
spite evidence that transfused murine and baboon plate-in which we reacted platelets with maximal concentra-
lets activated ex vivo by thrombin circulate normallytions of agonists, we have used 10- and 100-fold lower
with extensive shape changes (Berger et al., 1998; Mi-doses and have obtained comparable results (data not
chelson et al., 1996). Here, we have shown that chillingshown).
leads to specific changes in the platelet surface that
mediate their removal independently of shape change,
and that the shape change per se does not lead toMice with CR3 Receptors Rapidly Decrease Their
rapid platelet clearance. Chilled and rewarmed platelets,Platelet Counts When Exposed to Cold
preserved as discs with pharmacological agents, clearTemperatures; CR3/ Mice Have Increased Basal
with the same speed as untreated chilled platelets, andPlatelet Counts that Do Not Fall in the Cold
misshapen chilled and rewarmed platelets circulate likeAt RT CR3/ mice had platelet counts 20% higher
RT maintained platelets in CR3/ mice. The small size(2.26  0.18 	 109/ml) than their heterozygous lit-
of platelets may allow them to remain in the circulation,termates (1.88  0.16 	 109/ml, Mean  SD, n 
 8
escaping entrapment despite these extensive shape de-for both groups). The higher platelet count seen in the
formities.CR3/ mice follows a similar trend (10%) as pre-
viously described (Coxon et al. 1996). Within one half-
hour of residence in a 4C room, the platelet counts of Receptors Mediating Clearance of Chilled
control mice were detectably lower than baseline and Platelets: CR3 and GPIb
fell steadily to less than 80% of the initial value by 2 hr The normal platelet life span in humans and mice is 7
(1.4  0.16 	 109/ml). By contrast, the platelet counts days and 4 days, respectively (Aas and Gardner, 1958;
of CR3/ mice did not change in the cold (2.24 0.39	 Berger et al., 1998). The incorporation of platelets into
109/ml) (p 0.01) (Figure 7). During this interval the mice small blood clots engendered by continuous mechanical
were unrestrained and active, indicating maintenance stresses undoubtedly contributes to platelet clearance,
because massive thrombotic reactions, such as thoseof their core temperature despite exposure to the cold.
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Figure 7. Platelet Counts of CR3/ and Con-
trol Mice at Room Temperature and after Ex-
posure to the Cold
Platelets counts of CR3/mice (open circles)
and their heterozygote littermates (filled cir-
cles) were determined at RT and after their
residence in a 4C room for the indicated time
points. The bar represents the mean platelet
count value of 8 mice.
that occur during disseminated intravascular coagula- Activation also increases the amount of IIb3-integrin
and its avidity for fibrinogen (Shattil, 1999), but chillingtion, cause thrombocytopenia (Seligsohn, 1995). The
fate of platelets in animals exposed to thrombotic stimuli is without these effects. The normal survival of thrombin-
activated platelets is consistent with our findings.differs from that of infused ex vivo-activated platelets,
because in vivo platelet stimulation occurs on injured We have shown that CR3 on liver macrophages is
primarily responsible for the recognition and clearancevessel walls, and the activated platelets rapidly seques-
ter at these sites. of chilled platelets. The predominant role of CR3 bearing
liver macrophages in clearance of chilled platelets, de-Isoantibodies and autoantibodies accelerate the
phagocytic removal of platelets by Fc-receptor-bearing spite abundant CR3-expressing macrophages in the
spleen, is consistent with the principally hepatic clear-macrophages in individuals sensitized by immunologi-
cally incompatible platelets or in patients with autoim- ance of IgM-coated erythrocytes (Yan et al., 2000) and
may reflect blood filtration properties of the liver thatmune thrombocytopenia, but otherwise little information
exists regarding mechanisms of platelet clearance. We favor binding and ingestion by macrophage CR3. The
extracellular domain of GPIb, isolated by proteolysisshowed however, that the quantities of IgG or IgM bound
to chilled or RT human platelets are identical, implying from intact platelets, binds avidly to CR3 in vitro, and
when immobilized on a surface, supports the rollingthat binding of platelet-associated antibodies to Fc-
receptors does not mediate the clearance of cooled and firm adhesion of THP-1 cells (Simon et al., 2000).
Cleavage of the extracellular domain of murine GPIbplatelets. We also demonstrated that chilling of platelets
does not induce detectable PS exposure on the platelet results in normal survival of chilled platelets transfused
into mice. GPIb depletion of human chilled plateletssurface in vitro militating against PS exposure and the
involvement of scavenger receptors in the clearance of greatly reduces phagocytosis of the treated platelets
by macrophage-like cells in vitro. The finding that twochilled platelets.
Although publications have referred to effects of cold different enzymes, O-sialoglycoprotein endopeptidase
and mocarhagin, that target the extracellular domain ofon platelets as “activation”, aside from cytoskeletally
mediated shape changes, chilled platelets do not resem- mouse and human GPIb respectively, had identical
effects on CR3-mediated platelet recognition that sup-ble platelets activated by stimuli such as thrombin or
ADP. Normal activation markedly increases surface P ports the specificity of the enzyme treatment approach
for removal of GPIb. We propose, therefore, that GPIbselectin expression, a consequence of secretion from
intracellular granules (Berman et al., 1986). Chilling of is the counter-receptor on chilled platelets for liver mac-
rophage CR3 leading to their clearance by phagocy-platelets does not lead to upregulation of P selectin,
and the clearance of chilled platelets isolated from WT tosis.
The normal clearance of chilled platelets lacking theor P selectin/mice is equally rapid (Berger et al., 1998).
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Figure 8. Pathways Contributing to Basal
Platelet Clearance
Scheme depicting two platelet clearance
pathways. Platelets traverse central and pe-
ripheral circulations, undergoing reversible
priming at lower temperatures at the body
surface. Repeated priming leads to irrevers-
ible vWf receptor complex reconfiguration
and clearance by CR3 bearing hepatic mac-
rophages. Platelets are also cleared after they
participate in microvascular coagulation.
N-terminal portion of GPIb rules out the many other cation of GPIb might inhibit cold-induced platelet
clearance without impairment of GPIb’s hemostaticallyCR3 binding partners, including molecules expressed
on platelet surfaces as candidates for mediating chilled important reactivity with vWf. Should the clearance func-
tion of GPIb be subject to inhibition, tests of moreplatelet clearance. These ligand candidates include
ICAM-2, fibrinogen bound to the platelet integrin IIb3, subtle non-equilibrium interactions between GPIb and
vWf, such as shear-induced binding and platelet rollingiC3b, P selectin, glucosaminoglycans, and high molecu-
lar weight kininogen. We excluded deposition of the on vWf-coated surfaces, will be warranted (Goto et al.,
1995). Nevertheless, since all assays we performed ofopsonic C3b fragment iC3b as a mechanism for chilled
platelet clearance using mice deficient in complement function of cooled platelets in vitro and after infusion
into CR3/mice yielded grossly normal results, suitablyfactor 3, and the expression level of IIb3 and fibrinogen
binding are also unchanged after chilling of platelets. modified platelets might be reasonably effective in medi-
ating hemostasis. Previous studies have shown that
platelets stored in the cold have better in vitro functionBinding to Activated vWf and Cold-Induced
Binding to CR3 Appear to Be Separate than platelets stored at RT (Becker et al., 1973; Snyder
et al., 1989). The markedly shortened survival of chilledFunctions of GPIb
GPIb on the surface of the resting discoid platelet ex- platelets unfortunately offsets their functional advan-
tages.ists in linear arrays (Kovacsovics and Hartwig, 1996) in
a complex with GPIb, GPIX, and V, attached to the
submembrane actin cytoskeleton by filamin A and fil- Physiological Importance of Cold-Induced
Platelet Clearanceamin B (Lopez et al., 1998; Stossel et al., 2001). Its role
in hemostasis is to bind the activated form of vWf at Although gross platelet shape changes become obvious
only at temperatures below 15C, accurate biochemicalsites of vascular injury. GPIb binding to activated vWf
is constitutive and requires no active contribution from analyses show that cytoskeletal alterations and in-
creased responsiveness to platelet-activating media-the platelet since activated vWf binds equally well to
GPIb on resting or on stimulated platelets. Stimulation tors are detectable as the temperature falls below 37C
(Faraday and Rosenfeld, 1998; Hoffmeister et al., 2001).of platelets in suspension by thrombin and other ago-
nists causes GPIb to redistribute in part from the plate- We refer to those changes as “priming,” because cooling
does not by itself lead to changes associated with hemo-let surface into an internal membrane network, the open
canalicular system, but does not lead to platelet clear- static platelet activation other than alterations in mor-
phology (Faraday and Rosenfeld, 1998). We have pre-ance in vivo (Berger et al., 1998; Michelson et al., 1996)
or to phagocytosis in vitro (K.M.H., unpublished data). viously speculated that platelets are thermosensors,
designed to be less responsive to thrombogenic stimuliCooling of platelets however, causes GPIb clustering
rather than internalization. This clustering is indepen- at the core body temperature of the central circulation
where coronary or cerebral thrombosis could be lethal,dent of barbed end actin assembly, because it occurs
in the presence of cytochalasin B. Presumably, isolated but become primed for activation at the lower tempera-
tures of external body surfaces, sites most susceptibleGPIb extracellular domain fragments that bind CR3 in
vitro achieve this clustered conformation (Simon et al., to bleeding throughout evolutionary history (Hoffmeister
et al., 2001). The findings that prolonged (Deveci et al.,2000).
Despite cold’s promoting recognition of platelet 2001), and, as we report here, brief exposure to cold
diminishes the platelet counts of animals, support thisGPIb by CR3, it has no major effect on the interaction
between GPIb and activated vWf in vitro, and chilled hypothesis. The lack of a drop in platelet count in CR3/
mice is completely consistent with the operation of theplatelets transfused into vWf/ mice disappear as rap-
idly as in WT mice. The separability of GPIb’s interac- clearance pathway we have defined based on irrevers-
ible changes in GPIb, unrelated to its interaction withtion with vWf and CR3 suggests that selective modifi-
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RT maintained human or mouse platelets in buffer B, also containingvWf. Rather than allowing chilled platelets to circulate,
1 mM Ca2 and 10 g/ml of the snake venom metalloprotease mo-the organism clears low temperature-primed platelets
carhagin (provided by Dr. M. Berndt, Department of Biochemistryby CR3-mediated phagocytosis.
and Molecular Biology, Monash University, Clayton, VIC 3168, Aus-
A system involving at least two clearance pathways, tralia) (Ward et al., 1996) or 100 g/ml O-sialoglycoprotein endopep-
one for removal of locally activated platelets and another tidase (Cerladane, Hornby, Canada) (Bergmeier et al., 2001), respec-
tively. After the enzymatic digestion, human and mouse plateletsfor taking out excessively primed platelets (Figure 8),
were washed by centrifugation. GPIb removal from platelet surfacecan possibly explain why chilled platelets circulate and
was monitored by flow cytometry analysis (FACScalibur Flow Cyto-function normally in CR3/ mice and have a slightly
meter, Becton Dickinson Biosciences, San Jose, CA), using 5 g/ml
prolonged circulation following removal of GPIb. We of the FITC-conjugated anti-human GPIb (SZ2) mAb (Immunotech,
propose that some primed platelets enter microvascular Marseille, France) or 5 g/ml of the PE-anti-mouse GPIb mAb
thrombi on a stochastic basis. Others are susceptible pOp4, (Bergmeier et al., 2000).
Radioactive platelet clearance studies were performed with 111In-to repeated exposure to body surface temperature, and
dium (NEN Life Science Products, Boston, MA) loaded mouse plate-this repetitive priming eventually renders these platelets
lets (Kotze et al., 1985). Platelets, at a concentration of 2 	 109/mlrecognizable by CR3-bearing macrophages. Platelets
in 0.9% NaCl, [pH 6.5] were incubated with 500 Ci 111Indium for 30
primed by chilling are capable of relatively normal hemo- min at 37C, washed and suspended in buffer B.
static function in CR3/ mice, and coagulation contrib- For intravital microscopy or other platelet survival experiments,
utes to their clearance. Since the platelets of CR3/ platelets were labeled with 2.5M CellTracker Green CMFDA (Baker
et al., 1997) (Molecular probes, Inc. Eugene, OR) or with 0.15 Mmice have a somewhat shortened circulation time, pos-
TRITC (Sigma, St. Louis, MO) for 20 min at 37C in buffer B alsosibly resulting from increased clearance of primed plate-
containing 0.001% DMSO (Sigma, St. Louis, MO), and 20 mM HEPESlets in microvascular clots, increased platelet produc-
(GIBCO, Invitrogen Corp., Grand Island, NY). Unincorporated dye
tion must account for the slightly higher basal platelets was removed by centrifugation and platelets were suspended in
counts in these animals. If, as it has been proposed buffer B.
To inhibit cold-induced platelet shape changes, 109/ml platelets(Sungaran et al., 2000), platelet contents stimulate
in buffer B were loaded with 40 M EGTA-AM (Molecular probes,thrombopoetin production, an increase in the number
Inc. Eugene, OR) followed by 2 M cytochalasin B as previouslyof platelets being cleared by microvascular thrombosis
described (Winokur and Hartwig, 1995), labeled with 2.5 M CMFDAmight result in elevated platelet production. for 30 min at 37C, and then chilled or maintained at RT.
Experimental Procedures Platelet Temperature Protocols
To study the effects of temperature on platelet survival or function
Materials of unlabeled, radioactively, or fluorescently labeled mouse or human
We obtained: FITC-annexin V, PE-anti-human CD11b monoclonal platelets were incubated for 2 hr at RT (25C) or else at ice bath
antibodies (mAb), FITC-anti-mouse and anti-human IgM mAb, FITC- temperatures and then rewarmed for 15 min at 37C before transfu-
anti-mouse and anti-human CD62P mAb from Pharmingen, San sion into mice or in vitro analysis. Platelets subjected to these treat-
Diego, CA; FITC-rat anti-mouse and-human IgG mAb from Santa ments are designated as chilled or RT platelets.
Cruz Biotechnology, Inc., Santa Cruz, CA. Cytochalasin B, human
thrombin, PGE1 PMA from Sigma, St. Louis, MO. Murine Platelet Recovery, Survival, and Fate
CMFDA labeled chilled or RT murine platelets (108 ) were injected
Animals into syngeneic mice via the lateral tail vein. For recovery and survival
For assays of clearance and survival studies, we used age-, strain- determination, blood samples were collected immediately ( 2 min)
and sex-matched C57BL/J6 WT mice (Jackson Laboratory, Bar Har- and 0.5, 2, 24, 48, and 72 hr after transfusion into 0.1 volume of Aster-
bor, ME). Mice lacking complement component C3 (Wessels et al., Jandl anticoagulant. Whole blood analysis using flow cytometry
1995) (provided by Dr. M.C. Carroll, Center for Blood Research, was performed and the percentage of CMFDA positive platelets
Boston, MA) and CR3 (Coxon et al., 1996) were of the C57BL/6J determined (Baker et al., 1997). A total of 50,000 events were col-
129/sv genetic background. vWf/ mice were of the genetic C57BL/ lected in each sample. CMFDA positive platelets measured at a
J6 background (Denis et al., 1998). Heterozygote littermates were time  2 min was set as 100%. The recoveries were 72.8%  5.53
used as controls. Mice were maintained and treated as approved SD for RT stored platelets and 65.5  4.39 SD for chilled platelets.
by Harvard Medical Area Standing Committee on Animals according The mean platelet count per mouse was 1.55  0.23 SD 	 109/ml.
to NIH standards as set forth in The Guide for the Care and Use of The maximal percent of circulating labeled platelets, determined at
Laboratory Animals. 2 min was 5.3%  1.4 SD.
To evaluate the fate of platelets, tissues were harvested at 0.5,
Platelet Preparation 1, and 24 hr after the injection of 108 111Indium labeled chilled or RT
Platelets were isolated from normal human volunteers as described platelets into mice. Organ weight and radioactivity were determined
(Hartwig and Desisto, 1991). Human platelets used in the in vitro by -count. Results are expressed as % of radioactivity/per gm
phagocytosis assay were labeled with 1.8 M CellTracker Orange organ relative to the maximal radioactivity injected. For recovery
CMTMR (CM-Orange) (Molecular Probes, Inc., Eugene, OR) for 20 and survival determination of radioactive platelets, blood samples
min at 37C (Brown et al., 2000). Unincorporated dye was removed were collected into 0.1 volume of Aster-Jandl anticoagulant immedi-
by centrifugation (850 	 g, 5 min.) with 5 volumes of 140 mM NaCl, ately ( 2 min), 0.5, 1, and 24 hr after transfusion and their -count
5 mM KCl, 12 mM trisodium citrate, 10 mM glucose, 12.5 mM su- determined (Kotze et al., 1985).
crose, and 1 g/ml PGE1, [pH 6.0] (buffer A). Platelets were sus-
pended at 3 	 108/ml in 140 mM NaCl, 3 mM KCl, 0.5 mM MgCl2, 5 Platelet Aggregation
mM NaHCO3, 10 mM glucose, and 10 mM HEPES, [pH 7.4] (buffer B). Samples of 0.3 ml murine platelets were stirred and exposed to 1
Murine blood was obtained by retro orbital eye bleeding into 0.1 U/ml thrombin, 10 M ADP, or 3 g/ml CRP (Falet et al., 2002) at
volume of Aster-Jandl anticoagulant from anesthetized mice using 37C. Light transmission was recorded over 3 min (Bio/Data aggre-
3.75 mg/g of Avertin (Fluka Chemie, Steinheim, Germany) and centri- gometer, Horsham, PA).
fuged at 300 	 g for 8 min at RT to obtain PRP. Platelets were
separated from plasma proteins by centrifugation at 1200 	 g for Activated vWf Binding
5 min and washed in buffer A two times by centrifugation (1200 	 Platelet rich plasma was treated with 2 U/ml botrocetin (Centerchem
g for 5 min). Before injection into mice, platelets were suspended Inc., Norwalk, CT) for 5 min at 37C (Bergmeier et al., 2001). Bound
at a concentration of 1 	 109/ml in buffer B. vWf was detected by flow cytometry using a FITC-anti-vWf antibody
(DAKOCytomation, Glostrup, Denmark).GPIb was enzymatically removed from the surface of chilled or
Cell
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Surface Labeling of Platelet GPIb (Biorad, Hercules, CA) Images were captured and analyzed with
Laser Sharp 2000 software (Biorad).Resting mouse platelets maintained at RT or chilled were applied
to glass coverslips by centrifugation in PBS containing 0.05% glutar-
Platelet Aggregation in Shed Bloodaldehyde, fixed with 0.5% glutaraldehyde in PBS for 10 min.,
CMFDA labeled RT murine platelets (108 ) were injected into hetero-quenched with 0.1% sodium borohydride in PBS, and washed with
cygote littermate mice and 108 CMFDA labeled, chilled platelets intoPBS containing 1% BSA. GPIb was labeled with a mix of three
CR3/ mice. Twenty-four hrs after the platelet infusion, a standardrat anti-mouse GPIb monoclonal antibodies (provided by Dr. B.
bleeding time assay was performed, severing a 3 mm segment ofNieswandt, Witten/Herdecke University, Wuppertal, Germany), each
a mouse tail (Denis et al., 1998). The amputated tail was immersedat 10 g/ml for 1 hr, followed by one incubation with 10 nm gold
in 100 l of saline at 37C containing 0.1 volume of Aster-Jandlconjugated goat anti-rat IgG. The coverslips were washed, fixed
anticoagulant, shedding blood was collected for 2 min and fixedwith 1% glutaraldehyde, and prepared for electron microscopy as
with 1% paraformaldehyde (final concentration). Peripheral blooddescribed (Kovacsovics and Hartwig, 1996).
was obtained by retroorbital eye plexus bleeding, diluted 1/10 with
saline, and fixed with 1% paraformaldehyde. To analyze aggregates
In Vitro Phagocytic Assay in vivo by flow cytometry, blood shed from the wound and blood
Monocytic THP-1 cells (ATCC, Manassas,VA) were cultured for 7 obtained by eye bleeding were labeled with PE-anti-murine GPIb
days in RPMI 1640 cell culture media supplemented with 10% fetal mAb pOp4. The infused platelets were identified by their CMFDA
bovine serum, 25 mM HEPES, and 2 mM glutamine and differenti- labeling and discriminated from the CMFDA negative non-infused
ated using 1 ng/ml TGF-1 and 50 nM 1,25-(OH)2 vitamin D3 (Calbio- platelets. The number of platelet aggregates in shed blood was
chem, San Diego, CA) for 24 hr, which is accompanied by increased determined as described (Michelson et al., 1996).
expression of CR3 (Simon et al., 2000). CR3 expression was moni-
tored by flow cytometry using a PE-anti-human CD11b mAb. Undif- Flow Cytometric Analysis of Murine Platelet Fibrinogen
Binding and P Selectin Exposure of Circulating Plateletsferentiated or differentiated THP-1 cells (2 	 106/ml) were plated
RT and chilled CM-Orange-labeled platelets (108 ) were injected intoonto 24-well plates and allowed to adhere for 45 min at 37C. The
WT mice or CR3/ mice. The mice were bled at 24 hr and plateletsadherent macrophages were activated by the addition of 15 ng/ml
isolated. Resting or thrombin activated (1 U/ml, 5 min) platelets (2	PMA for 15 min. CM-Orange-labeled, chilled, or RT platelets (107/
108 ) were diluted in PBS and stained with FITC-anti-mouse CD62Pwell), previously subjected to different treatments were added to the
mAb or Oregon Green-fibrinogen. Platelet samples were analyzedphagocytes in Ca2- and Mg2- containing HBSS (GIBCO Invitrogen,
by flow cytometry. CD62P expression and fibrinogen binding wereGrand Island, NY) and incubated for 30 min at 37C. The phagocyte
measured for each CM-Orange positive and negative populationmonolayer was washed for 3 times with HBSS, and adherent plate-
before and after stimulation with thrombin.lets were removed by treatment with 0.05% trypsin/0.53 mM EDTA
in HBSS (GIBCO Invitrogen, Grand Island, NY) at 37C for 5 min
Effect of Exposure of Mice to Cold Temperaturesfollowed by 5 mM EDTA at 4C to detach the macrophages (Brown
on Their Platelet Countset al., 2000) for flow cytometry analysis. Human CM-Orange-labeled,
Eight-week-old mice/ in CR3 and their WT littermates of bodychilled, or RT platelets expressed the same amount of the platelet
mass of25 g were exposed to 4C air temperatures for two hours.specific marker CD61 (not shown). Platelets were resolved from the
The mice were freely mobile during that interval. Ten l of bloodphagocytes according to their forward and side scatter characteris-
was obtained by a standard bleeding time assay, severing a 3 mmtics. The macrophages were gated and 10,000 events acquired for
segment of each mouse tail. Emerging blood was collected aftereach sample. CM-Orange-labeled platelets that associate with the
0.5, 1, and 2 hr into 0.1 volume of Aster-Jandl anticoagulant. Thephagocyte population shift in orange fluorescence (Figure 6A and
platelet count was determined was determined by flow cytometryFigure 6B, ingested, y axis). Platelets adherent to macrophages
using reference beads (SPHERO rainbow fluorescent beads, 5.5 mwere not present because the macrophages failed to dual label with
diameter, Spherotech Inc., Libertyville, IL) as described (Alugupallithe FITC-mAb to human-CD61 (Accurate Scientific, Westbury, NY).
et al., 2001).
StatisticsImmunolabeling and Flow Cytometry of Platelets
The intravital microscopy data are expressed as means  SEM.Washed murine or human platelets were analyzed for surface ex-
Groups were compared using the nonpaired t test. P values  0.05pression of CD62P, CD61, or surface bound IgM and IgG after chill-
were considered significant. All other data are presented as theing or RT storage by staining with fluorophore-conjugated Abs (5
mean  SD.g/ml) for 10 min at 37C. Phosphatidylserine exposure by chilled
or room temperature platelets was determined by FITC-conjugated
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